Published in Arch Intern Med on October 25, 2004
Adverse interaction of warfarin and paracetamol: evidence from a post-mortem study. Eur J Clin Pharmacol (2009) 1.44
Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics. Scand J Prim Health Care (2007) 1.00
A prospective analysis of the preventability of adverse drug reactions reported in Sweden. Eur J Clin Pharmacol (2012) 0.82
Complication of warfarin therapy presenting as empyema. J Thorac Dis (2011) 0.80
Factors associated with INR elevation and bleeding complications during Warfarin therapy. Arch Intern Med (2005) 0.78
Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med (2014) 9.33
Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med (2009) 9.17
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet (2008) 9.10
Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65
Electronic alerts to prevent venous thromboembolism among hospitalized patients. N Engl J Med (2005) 7.90
Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials. JAMA (2011) 7.61
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Extended use of dabigatran, warfarin, or placebo in venous thromboembolism. N Engl J Med (2013) 6.71
Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation (2006) 5.31
Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation (2011) 5.16
Influence of androgen suppression therapy for prostate cancer on the frequency and timing of fatal myocardial infarctions. J Clin Oncol (2007) 5.12
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation (2003) 4.61
Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry. J Am Coll Cardiol (2003) 4.10
Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation (2004) 3.83
Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation (2013) 3.73
Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med (2009) 3.73
Chronic thromboembolic pulmonary hypertension. N Engl J Med (2011) 3.37
2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2011) 2.71
2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol (2014) 2.58
Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg (2008) 2.55
Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg (2005) 2.53
Effect of computerized clinical decision support on the use and yield of CT pulmonary angiography in the emergency department. Radiology (2011) 2.47
Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med (2003) 2.47
Physical inactivity and idiopathic pulmonary embolism in women: prospective study. BMJ (2011) 2.34
Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med (2011) 2.32
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II. Circulation (2003) 2.28
Massive pulmonary embolism. Circulation (2006) 2.27
Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol (2007) 2.27
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol (2005) 2.25
The accuracy of the enzyme-linked immunosorbent assay D-dimer test in the diagnosis of pulmonary embolism: a meta-analysis. Ann Emerg Med (2002) 2.25
Right ventricular enlargement on chest computed tomography: prognostic role in acute pulmonary embolism. Circulation (2004) 2.21
The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage. Arch Intern Med (2004) 2.11
Upper-extremity deep vein thrombosis. Circulation (2002) 2.09
Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation (2004) 2.05
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J (2013) 2.02
Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. Am J Med (2008) 1.98
Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation (2004) 1.97
2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol (2009) 1.86
Clinical validity of a negative computed tomography scan in patients with suspected pulmonary embolism: a systematic review. JAMA (2005) 1.82
Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med (2005) 1.76
Normal D-dimer levels in emergency department patients suspected of acute pulmonary embolism. J Am Coll Cardiol (2002) 1.75
Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation (2007) 1.75
Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. Am J Manag Care (2004) 1.69
Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation (2003) 1.68
Physician alerts to prevent symptomatic venous thromboembolism in hospitalized patients. Circulation (2009) 1.66
Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation (2004) 1.65
Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial. Arch Intern Med (2005) 1.64
Surgical pulmonary embolectomy: the resurrection of an almost discarded operation. Tex Heart Inst J (2013) 1.63
Percutaneous mechanical thrombectomy for acute pulmonary embolism: a double-edged sword. Chest (2007) 1.60
Assessing the prognosis of acute pulmonary embolism: tricks of the trade. Chest (2008) 1.54
Venous thromboembolism in patients with symptomatic atherosclerosis. Thromb Haemost (2011) 1.52
Medication use evaluation: pharmacist rubric for performance improvement. Pharmacotherapy (2014) 1.52
Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004. Circulation (2011) 1.51
Abnormal cytology predicts poor prognosis in cancer patients with pericardial effusion. J Clin Oncol (2005) 1.50
Thrombosis in suspected heparin-induced thrombocytopenia occurs more often with high antibody levels. Am J Med (2011) 1.48
Acute pulmonary embolectomy: a contemporary approach. Circulation (2002) 1.44
Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol (2005) 1.42
Diagnosis of acute pulmonary embolism: always be vigilant. Am J Med (2007) 1.41
Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomy. Chest (2002) 1.40
Egg consumption is the principal risk factor for sporadic Salmonella serotype Heidelberg infections: a case-control study in FoodNet sites. Clin Infect Dis (2004) 1.40
Improving clinical effectiveness in thromboprophylaxis for hospitalized medical patients. Am J Med (2009) 1.39
Randomized trial of physician alerts for thromboprophylaxis after discharge. Am J Med (2013) 1.39
Anything but beryllium: the beryllium industry's corruption of safety information. Am J Ind Med (2002) 1.39
Optimal duration of anticoagulation after venous thromboembolism: fixed and evidence-based, or flexible and personalized? Ann Intern Med (2009) 1.36
Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 1.36
Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol (2005) 1.34
Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation (2003) 1.32
Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol (2007) 1.31
CT signs of right ventricular dysfunction: prognostic role in acute pulmonary embolism. JACC Cardiovasc Imaging (2011) 1.30
Multislice computed tomography for pulmonary embolism--a technological marvel. N Engl J Med (2005) 1.28
Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004. Circulation (2008) 1.28
Fibrinolysis for acute pulmonary embolism. Vasc Med (2010) 1.27
Management of massive pulmonary embolism. Circulation (2005) 1.27
Routine pelvic and lower extremity CT venography in patients undergoing pulmonary CT angiography. AJR Am J Roentgenol (2008) 1.22
Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey. Thromb Haemost (2010) 1.21
International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J (2011) 1.20
Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (Multicenter Emergency Medicine Pulmonary Embolism in the Real World Registry). J Am Coll Cardiol (2011) 1.19
Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost (2005) 1.19
2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline). Vasc Med (2011) 1.19
Acute pulmonary embolism: part II: treatment and prophylaxis. Circulation (2006) 1.16
Prospective study of BMI and the risk of pulmonary embolism in women. Obesity (Silver Spring) (2009) 1.14